Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Erica L, Goodrich"'
Autor:
Ankeet S. Bhatt, Anubodh S. Varshney, Erica L. Goodrich, Jingyi Gong, Curtis Ginder, Balimkiz C. Senman, Matthew Johnson, Kayleigh Butler, Ann E. Woolley, James A. de Lemos, David A. Morrow, Erin A. Bohula
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection. However, the epidemiology of STEMI in patients with COVI
Externí odkaz:
https://doaj.org/article/ecc44afeefd44bb6b450edbe35f89fa8
Autor:
David D. Berg, Benjamin L. Freedman, Marc P. Bonaca, Petr Jarolim, Benjamin M. Scirica, Erica L. Goodrich, Marc S. Sabatine, David A. Morrow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Patients with stable atherothrombotic disease vary in their risk of developing heart failure (HF). Circulating cardiovascular biomarkers may improve HF risk assessment and identify patients who may benefit from emerging HF preventive thera
Externí odkaz:
https://doaj.org/article/6e3d75915fc5499bb2bf69f456300b41
Autor:
Ofri Mosenzon, Itamar Raz, Stephen D. Wiviott, Meir Schechter, Erica L. Goodrich, Ilan Yanuv, Aliza Rozenberg, Sabina A. Murphy, Thomas A. Zelniker, Anna Maria Langkilde, Ingrid A.M. Gause-Nilsson, Martin Fredriksson, Peter A. Johansson, John P.H. Wilding, Darren K. McGuire, Deepak L. Bhatt, Lawrence A. Leiter, Avivit Cahn, Jamie P. Dwyer, Hiddo J.L. Heerspink, Marc S. Sabatine
Publikováno v:
Diabetes Care, 45(10), 2350-2359. AMER DIABETES ASSOC
OBJECTIVE In patients with moderate to severe albuminuric kidney disease, sodium–glucose cotransporter 2 inhibitors reduce the risk of kidney disease progression. These post hoc analyses assess the effects of dapagliflozin on kidney function declin
Autor:
Benjamin L. Freedman, David D. Berg, Benjamin M. Scirica, Erin A. Bohula, Erica L. Goodrich, Marc S. Sabatine, David A. Morrow, Marc P. Bonaca
Publikováno v:
Clinical Cardiology. 45:831-838
Heart failure (HF) is a growing public health problem and ischemic heart disease is an important risk factor. Understanding the epidemiology of HF in patients with atherosclerosis may help identify subgroups at greater risk who have the potential to
Autor:
Simon Correa, David A. Morrow, Eugene Braunwald, Richard Y. Davies, Erica L. Goodrich, Sabina A. Murphy, Christopher P. Cannon, Michelle L. O'Donoghue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 20 (2018)
Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations. The incremental value of Cys‐C beyond established cardiac and renal biomarker
Externí odkaz:
https://doaj.org/article/42a70a77259546399553720ba4245549
Autor:
Darren K. McGuire, John P.H. Wilding, Marc S. Sabatine, Avivit Cahn, Thomas A Zelniker, Hiddo J. Lambers Heerspink, Lawrence A. Leiter, KyungAh Im, Itamar Raz, Deepak L. Bhatt, Erica L. Goodrich, Stephen D. Wiviott, Jamie P. Dwyer, Anna Maria Langkilde, Ofri Mosenzon, Ingrid Gause-Nilsson
Publikováno v:
JAMA Cardiol
Jama cardiology, 6(7), 811-819. AMER MEDICAL ASSOC
JAMA Cardiology
Jama cardiology, 6(7), 811-819. AMER MEDICAL ASSOC
JAMA Cardiology
ImportanceSodium-glucose cotransporter 2 inhibitors, such as dapagliflozin, promote renal glucose excretion and reduce cardiovascular (CV) deaths and hospitalizations for heart failure (HHF) among patients with type 2 diabetes. The relative CV effica
Autor:
Benjamin L. Freedman, David D. Berg, Benjamin M. Scirica, Erin A. Bohula, Erica L. Goodrich, Marc S. Sabatine, David A. Morrow, Marc P. Bonaca
Publikováno v:
Clinical Cardiology. 46:348-349
Autor:
Laura K. Barger, Shantha M.W. Rajaratnam, Christopher P. Cannon, Mary Ann Lukas, KyungAh Im, Erica L. Goodrich, Charles A. Czeisler, Michelle L. O'Donoghue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundIt is unknown whether short sleep duration, obstructive sleep apnea, and overnight shift work are associated with the risk of recurrent cardiovascular events in patients after an acute coronary syndrome. Methods and ResultsSOLID‐TIMI 52 (
Externí odkaz:
https://doaj.org/article/547e2f6d1e7949b4ba1c1568a6567300
Autor:
Christina L. Fanola, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Mary Ann Lukas, Christoph Bode, Judith S. Hochman, Erica L. Goodrich, Eugene Braunwald, Michelle L. O'Donoghue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundInterleukin‐6 (IL‐6) is an inflammatory cytokine implicated in plaque instability in acute coronary syndrome (ACS). We aimed to evaluate the prognostic implications of IL‐6 post‐ACS. Methods and ResultsIL‐6 concentration was asses
Externí odkaz:
https://doaj.org/article/8971847489b84804b384a603397b21fc
Autor:
Alon Eisen, Christopher P. Cannon, Eugene Braunwald, Dylan L. Steen, Jing Zhou, Erica L. Goodrich, KyungAh Im, Anthony J. Dalby, Jindrich Spinar, Shruti Daga, Mary Ann Lukas, Michelle L. O'Donoghue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 1 (2017)
BackgroundHigh‐potency statins reduce cardiovascular events after acute coronary syndromes but remain underused in clinical practice. We examined predictors of nonuse of high‐potency statins after acute coronary syndromes. Methods and ResultsThe
Externí odkaz:
https://doaj.org/article/4f8ca7a9a917490f9b000561507fba98